III Central Asian Neurological Forum “Current Issues in Clinical Neurology and Neurorehabilitation”

From February 28 to March 1, 2025, the III Central Asian Neurological Forum “Current Issues in Clinical Neurology and Neurorehabilitation” was held in Almaty, dedicated to the 95th anniversary of S.D. Asfendiyarov Kazakh National Medical University (KazNMU).

The Role of Adjuvants in Pain Syndrome Therapy

On February 20, a webinar on the topic “The Role of Adjuvants in Pain Syndrome Therapy” was held for neurologists, general practitioners, therapists, and residents. The webinar was conducted by the Head of the Department of Nervous Diseases at KazNMU, Chief Neurologist of the Ministry of Health of the Republic of Kazakhstan, Turupekova S.T.

Somatoform Disorders: Modern Approaches to Diagnosis and Treatment

On February 20, 2025, in Almaty, a multidisciplinary expert working meeting was held with the participation of neurologists, psychiatrists, cardiologists, and general practitioners on the topic “Somatoform Disorders: Modern Approaches to Diagnosis and Treatment”

Biotechnology in Kazakhstan: Trust, Care, Freedom!

On February 8 and 15, 2025, educational events were held in Almaty and Astana dedicated to improving the quality of life for patients with generalized myasthenia gravis (MG) and neuromyelitis optica spectrum disorder (NMOSD) through biotechnology

XXI Interdisciplinary Congress with International Participation “Wein Readings”

On February 10-12, 2025, the 21st Interdisciplinary Congress with international participation, “Wein Readings,” was held in Moscow

Almaty to Become a Center for International Stroke Research: KazNMU and City Emergency Hospital Join Global Scientific Project

On February 5, 2025, a research center was inaugurated in Almaty to participate in the multicenter international clinical study CTF-NIS-2024. The research is being conducted at the Municipal State Enterprise on the Right of Economic Management “City Emergency Hospital” . This center is the only one in Kazakhstan and the 25th participant in the global non-interventional post-registration study